Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Description

This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.

Conditions

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Condition
Hematopoietic and Lymphatic System Neoplasm
Intervention / Treatment

-

Contacts and Locations

Jacksonville

Mayo Clinic in Florida, Jacksonville, Florida, United States, 32224-9980

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * \* Any patient \>= 18 years of age
  • * Planned or receiving any potentially toxic cancer therapy including but not limited to chemotherapy, targeted and immunotherapies
  • * Inability on the part of the patient to understand the informed consent or be compliant with the protocol

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Nadine Norton, PhD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2026-12-15